Addus HomeCare EVP sells $165,731 in stock

Published 25/02/2025, 22:02
Addus HomeCare EVP sells $165,731 in stock

Sean Gaffney, Executive Vice President and Chief Legal Officer at Addus HomeCare Corp (NASDAQ:ADUS), a healthcare services provider with over $1.1 billion in annual revenue and an "GREAT" financial health rating according to InvestingPro, recently sold 1,532 shares of the company’s stock. The transaction, dated February 24, was executed at a price of $108.18 per share, resulting in a total sale value of approximately $165,731. The stock currently appears undervalued based on InvestingPro’s Fair Value analysis. This sale was conducted under a pre-established 10b5-1 plan, primarily to cover tax obligations related to the vesting of restricted stock awards.

Earlier, on February 21, Gaffney acquired 5,150 shares of common stock at no cost, as part of his compensation package. These shares will vest in equal installments over the next three years, provided certain conditions are met. Following these transactions, Gaffney holds 18,658 shares of Addus HomeCare stock directly. For comprehensive insider trading analysis and 12 additional ProTips about ADUS, visit InvestingPro.

In other recent news, Addus HomeCare Corporation reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $1.38, compared to the forecasted $1.35. The company’s revenue also exceeded projections, reaching $297.1 million against an anticipated $284.28 million. Despite these positive financial results, Addus HomeCare’s stock experienced a decline, which could be attributed to broader market concerns or specific challenges faced by the company. The company completed a significant acquisition and introduced new technology aimed at improving caregiver services. Analyst firms have taken note of these developments, although no specific upgrades or downgrades were mentioned. Addus HomeCare continues to face challenges in the clinical labor market, particularly with nursing staff, and potential changes in Medicaid policy remain a concern. The company’s full-year revenue reached $1.2 billion, reflecting a 9.1% increase from the previous year, highlighting its growth strategy and successful acquisition integration.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.